×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| KILITCH DRUGS (INDIA) LTD. | 376.17 | 47.94 | 341.22 | 2.98 | 634.0 | 22.6 |
| Fredun Pharmaceuticals Limited | NA | NA | NA | NA | 626 | 26.7 |
| VENUS REMEDIES LTD. | 1398.5 | 116.9 | 1318.5 | 8.75 | 611 | 13.1 |
Kilitch Drugs (I) Ltd., with Security Code 524500, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 43.3 | 31.1 | 31.6 | 29.8 | 39.1 | 33.4 | 45.3 | 46.5 | 56.3 | 34.1 |
| Expenses | 36.6 | 25.9 | 25.9 | 25.7 | 33.9 | 30.2 | 39.8 | 38.4 | 42.4 | 30.6 |
| Operating Profit | 6.7 | 5.2 | 5.7 | 4.0 | 5.2 | 3.2 | 5.6 | 8.1 | 13.9 | 3.6 |
| OPM % | 15.45% | 16.83% | 18.11% | 13.5% | 13.33% | 9.63% | 12.33% | 17.45% | 24.75% | 10.47% |
| Other Income | 1.4 | 1.0 | 0.9 | 3.4 | 0.9 | 3.2 | 5.8 | 2.4 | 2.3 | 3.5 |
| Interest | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.5 | 0.4 | 0.5 | 0.7 | 0.6 |
| Depreciation | 0.4 | 0.3 | 0.3 | 0.3 | 0.4 | 0.3 | 0.4 | 0.5 | 0.5 | 0.5 |
| Profit before tax | 7.3 | 5.6 | 5.9 | 6.6 | 5.3 | 5.6 | 10.6 | 9.5 | 15.0 | 6.0 |
| Tax % | -30.1% | -24.9% | -28.5% | -16.4% | -30.7% | 27.5% | -16.4% | -27.7% | -24% | 19.9% |
| Net Profit | 5.1 | 4.2 | 4.2 | 5.5 | 3.6 | 4.1 | 8.8 | 6.9 | 11.4 | 4.8 |
| EPS in Rs | 3.29 | 2.69 | 2.6 | 3.48 | 2.26 | 2.52 | 5.5 | 4.28 | 0 | 2.98 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30.0 | 45.5 | 36.6 | 41.2 | 31.8 | 44.8 | 33.5 | 47.5 | 56.2 | 61.2 |
| Expenses | 26.0 | 39.3 | 30.4 | 32.6 | 29.5 | 37.7 | 31.8 | 41.4 | 47.4 | 46.6 |
| Operating Profit | 4.0 | 6.2 | 6.2 | 8.6 | 2.3 | 7.1 | 1.7 | 6.1 | 8.7 | 14.7 |
| OPM % | 13.28% | 13.66% | 16.9% | 20.92% | 7.17% | 15.79% | 4.96% | 12.83% | 15.55% | 23.97% |
| Other Income | 0.7 | 1.0 | 0.6 | 0.5 | 3.0 | 0.5 | 2.6 | 5.2 | 1.7 | 1.7 |
| Interest | 1.3 | 1.2 | 1.5 | 1.5 | 1.6 | 1.3 | 1.7 | 0.3 | 1.4 | 1.6 |
| Depreciation | 0.9 | 0.9 | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | 0.6 | 0.8 | 0.8 |
| Profit before tax | 2.5 | 5.1 | 4.5 | 6.8 | 2.8 | 5.3 | 1.7 | 10.3 | 8.3 | 13.9 |
| Tax % | -30.3% | -43.3% | -31.3% | -24.9% | -38.3% | -30.5% | -93.2% | 16.8% | 31.9% | -26% |
| Net Profit | 1.7 | 2.9 | 3.1 | 5.1 | 1.7 | 3.7 | 0.1 | 8.6 | 5.6 | 10.2 |
| EPS in Rs | 1.52 | 2.29 | 2.15 | 2.93 | 1.85 | 2.24 | 0.83 | 5.36 | 3.71 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 24% |
| 3 Years: | 20% |
| TTM: | 38% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 48% |
| 5 Years: | 61% |
| 3 Years: | 48% |
| TTM: | 86% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 38% |
| 3 Years: | 44% |
| 1 Year: | 37% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 30% |
| 3 Years: | 20% |
| TTM: | 28% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 42% |
| 5 Years: | 161% |
| 3 Years: | 67% |
| TTM: | 97% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 38% |
| 3 Years: | 44% |
| 1 Year: | 37% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|